# Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

> **NCT02526875** · PHASE4 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 208 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telminuvo®Tab. 40/2.5mg

## Key facts

- **NCT ID:** NCT02526875
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02526875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02526875, "Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02526875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*